GTCR Completes the Sale of Antylia Scientific for $1.34 Billion GTCR, a prominent private equity firm, has finalized the $1.34 billion sale of Antylia Scientific, marking the end of a transformative partnership.

GTCR Completes the Sale of Antylia Scientific for $1.34 Billion #United_States #Brookfield #GTCR #Vernon_Hills #Antylia

@genseq.bsky.social @carlzeissstiftung.bsky.social #NewEnglandBiolabs #Merck #VWR #Abcam #BioRad #MirusBio #Novartis #StellaScientific #Cole-Parmer #Antylia #Thermo #FisherScientific